ArticleClinical and translational gastroenterology2025

Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapies Linked to Insurance Delays, Intravenous Infusions, and Lack of Pharmacy Support.

Sara Gottesman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.